Real-world Secukinumab Outcomes in Canadian HS Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-world Secukinumab Outcomes in Canadian HS Patients — Stella

Recruiting

Back to Hidradenitis Suppurativa trials

Trial locations(11 sites)

Canada

Novartis Investigative Site, Calgary, Alberta

Novartis Investigative Site, Winnipeg, Manitoba

Novartis Investigative Site, Cobourg, Ontario

Novartis Investigative Site, Hamilton, Ontario

Novartis Investigative Site, London, Ontario

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~142 participants

Started

December 2025

Primary completion

February 2028

Age range

18 Years – 100 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov